Ryosuke Amano
Impact in
- Oncology top 2%
- Pancreatic and Hepatic Oncology Research
- Inflammatory Biomarkers in Disease Prognosis
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- Cancer Research top 10%
Papers in
- Co-authors
- Kosei Hirakawa (95 shared papers)Masaichi Ohira (84 shared papers)Kenjiro Kimura (87 shared papers)Masakazu Yashiro (49 shared papers)Hiroaki Tanaka (51 shared papers)Kazuya Muguruma (52 shared papers)Naoshi Kubo (41 shared papers)Katsunobu Sakurai (35 shared papers)
- Journals
- Anticancer Research (7 papers)World Journal of Surgery (6 papers)BMC Cancer (6 papers)Annals of Gastroenterological Surgery (5 papers)BMC Surgery (5 papers)
- Partner nations
- JapanUnited StatesGermany
In The Last Decade
Ryosuke Amano
135 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 84
- Oncology 1.2k
- Cancer Research 259
- Hepatology 132
- Pulmonary and Respiratory Medicine 397
- Surgery 489
Countries citing papers authored by Ryosuke Amano
This map shows the geographic impact of Ryosuke Amano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryosuke Amano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryosuke Amano more than expected).
Fields of papers citing papers by Ryosuke Amano
This network shows the impact of papers produced by Ryosuke Amano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryosuke Amano. The network helps show where Ryosuke Amano may publish in the future.
Co-authors
The 25 scholars most cited alongside Ryosuke Amano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 140 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 182 | |
| 2 | 2015 | 133 | |
| 3 | 2009 | 100 | |
| 4 | 2017 | 84 | |
| 5 | 2017 | 82 | |
| 6 | Programmed Death-1 Ligand-1 (PDL1) Expression Is Associated with the Prognosis of Patients with Stage II/III Gastric Cancer. | 2015 | 78 |
| 7 | 2016 | 65 | |
| 8 | 2011 | 58 | |
| 9 | 2016 | 54 | |
| 10 | 2013 | 51 | |
| 11 | 2019 | 50 | |
| 12 | 2015 | 48 | |
| 13 | 2010 | 48 | |
| 14 | 2008 | 46 | |
| 15 | 2021 | 46 | |
| 16 | 2013 | 43 | |
| 17 | The impact of combined thoracoscopic and laparoscopic surgery on pulmonary complications after radical esophagectomy in patients with resectable esophageal cancer. | 2014 | 42 |
| 18 | 2016 | 42 | |
| 19 | 2015 | 42 | |
| 20 | 2014 | 39 |
About Ryosuke Amano
Ryosuke Amano is a scholar working on Oncology, Surgery, Pulmonary and Respiratory Medicine, Hepatology and Cancer Research, having authored 140 papers that have together received 2.4k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (19 papers), Inflammatory Biomarkers in Disease Prognosis (14 papers), Metastasis and carcinoma case studies (13 papers), Gastric Cancer Management and Outcomes (12 papers), Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Esophageal Cancer Research and Treatment (9 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers) and Esophageal and GI Pathology (6 papers). The work is most often cited by research in Oncology (1.2k citations), Cancer Research (259 citations), Hepatology (132 citations), Pulmonary and Respiratory Medicine (397 citations) and Surgery (489 citations). Ryosuke Amano has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Kosei Hirakawa, Masaichi Ohira, Kenjiro Kimura, Masakazu Yashiro, Hiroaki Tanaka, Kazuya Muguruma, Naoshi Kubo, Katsunobu Sakurai, Takahiro Toyokawa and Kiyoshi Maeda. Their work appears in journals such as Anticancer Research, World Journal of Surgery, BMC Cancer, Annals of Gastroenterological Surgery and BMC Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.